15th Anniversary of Pharmaceutics—Advances in Process and Formulation Modeling

Dear Colleagues,

The modeling of processes and formulations, being an inherent component of quality by design (QbD), has significantly enhanced product development in the pharmaceutical industry. During process development, engineers routinely consolidate computational fluid dynamics, population balance models, discrete element models and their combination. Modeling helps scientists, formulators and engineers gain fundamental insights and understanding, leading to a streamlined and faster development of pharmaceutical products.

This Special Issue aims to bring academics and industry practitioners to disseminate recent advances in the development, application, training, testing and validation of models. While there is no restriction on the type of models, with possibilities of including mechanistic, phenomenological, stochastic, molecular, statistical or hybrid models, novel studies are expected to discuss how to design, optimize and intensify pharmaceutical processes and formulations. Hence, reports that solely focus on experimental work or computational method development are not of significant interest. In this context, studies on the following topics are especially welcome: new process development areas, such as continuous manufacturing and 3D-additive manufacturing; the simulation, control and scale-up of pharmaceutical processes; development of hybrid, coupled and/or multi-scale models; machine learning and data mining for process formulation development; and models for various in vivo and in vitro performance tests, including dissolution tests, permeability tests and/or PKPD models.

Prof. Dr. Ecevit Bilgili
Dr. Sadegh Poozesh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.